These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35585575)
21. High COVID-19 death rates in prisons in England and Wales, and the need for early vaccination. Braithwaite I; Edge C; Lewer D; Hard J Lancet Respir Med; 2021 Jun; 9(6):569-570. PubMed ID: 33740466 [No Abstract] [Full Text] [Related]
22. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602 [TBL] [Abstract][Full Text] [Related]
23. COVID-19 Cases Among Employees of U.S. Federal and State Prisons. Ward JA; Parish K; DiLaura G; Dolovich S; Saloner B Am J Prev Med; 2021 Jun; 60(6):840-844. PubMed ID: 33750599 [TBL] [Abstract][Full Text] [Related]
24. Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries. Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT Front Public Health; 2024; 12():1279572. PubMed ID: 38560445 [TBL] [Abstract][Full Text] [Related]
25. Investigation of a COVID-19 outbreak at a regional prison, Northern Uganda, September 2020. Migisha R; Morukileng J; Biribawa C; Kadobera D; Kisambu J; Bulage L; Ndyabakira A; Katana E; Mills LA; Ario AR; Harris JR Pan Afr Med J; 2022; 43():10. PubMed ID: 36284891 [TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 seroprevalence study after the first wave among persons living and working in an overcrowded Swiss prison. Gétaz L; Wolff H; Gonçalves L; Togni G; Stringhini S; Chacowry Pala K; Iten A; Guessous I; Kaiser L; Chappuis F; Baggio S Int J Prison Health; 2022 Oct; ():. PubMed ID: 36269138 [TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review. Ismail N; Tavoschi L; Moazen B; Roselló A; Plugge E PLoS One; 2022; 17(9):e0267070. PubMed ID: 36084037 [TBL] [Abstract][Full Text] [Related]
28. Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons. Ortiz-Paredes D; Varsaneux O; Worthington J; Park H; MacDonald SE; Basta NE; Lebouché B; Cox J; Ismail SJ; Kronfli N PLoS One; 2022; 17(3):e0264145. PubMed ID: 35263350 [TBL] [Abstract][Full Text] [Related]
29. Attitudes towards COVID-19 vaccination among incarcerated persons in the Federal Bureau of Prisons, June-July 2021. Fukunaga R; Kaplan ZE; Rodriguez T; Hagan L; Aarvig K; Dusseau C; Crockett M; Long M Vaccine; 2023 Jun; 41(24):3604-3610. PubMed ID: 37164822 [TBL] [Abstract][Full Text] [Related]
30. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M; Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846 [TBL] [Abstract][Full Text] [Related]
31. Prison Population Reductions and COVID-19: A Latent Profile Analysis Synthesizing Recent Evidence From the Texas State Prison System. Vest N; Johnson O; Nowotny K; Brinkley-Rubinstein L J Urban Health; 2021 Feb; 98(1):53-58. PubMed ID: 33337529 [TBL] [Abstract][Full Text] [Related]
32. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607 [TBL] [Abstract][Full Text] [Related]
33. Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England. Vusirikala A; Flannagan J; Czachorowski M; Zaidi A; Twohig KA; Plugge E; Ellaby N; Rice W; Dabrera G; Chudasama DY; Lamagni T Public Health; 2022 Mar; 204():21-24. PubMed ID: 35131679 [TBL] [Abstract][Full Text] [Related]
34. Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis. Gurdasani D; Bhatt S; Costello A; Denaxas S; Flaxman S; Greenhalgh T; Griffin S; Hyde Z; Katzourakis A; McKee M; Michie S; Ratmann O; Reicher S; Scally G; Tomlinson C; Yates C; Ziauddeen H; Pagel C J R Soc Med; 2021 Nov; 114(11):513-524. PubMed ID: 34723680 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons. Kramer C; Song M; Sufrin CB; Eber GB; Rubenstein LS; Saloner B Vaccine; 2023 Feb; 41(7):1408-1417. PubMed ID: 36690558 [TBL] [Abstract][Full Text] [Related]
36. Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population. Sutton AJ; Gay NJ; Edmunds WJ; Gill ON Epidemiol Infect; 2008 Dec; 136(12):1644-9. PubMed ID: 18346286 [TBL] [Abstract][Full Text] [Related]
37. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222 [TBL] [Abstract][Full Text] [Related]
38. Incarcerated workers: overlooked as essential workers. Segule MN; LeMasters K; Peterson M; Behne MF; Brinkley-Rubinstein L BMC Public Health; 2022 Mar; 22(1):506. PubMed ID: 35291982 [TBL] [Abstract][Full Text] [Related]
39. Testing for COVID-19 during an outbreak within a large UK prison: an evaluation of mass testing to inform outbreak control. Blackmore C; Czachorowski M; Farrington E; O'Moore É; Plugge E Int J Infect Dis; 2022 Dec; 125():138-144. PubMed ID: 36265822 [TBL] [Abstract][Full Text] [Related]
40. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]